NEW YORK (GenomeWeb News) – Cellectis bioresearch, a subsidiary of Cellectis group, today said that it has partnered with Stemgent to provide research services that combine mRNA reprogramming and genome engineering.

The firms said that the combination of their technologies would "pave the way for clinically-relevant applications in regenerative medicine." Terms of the alliance were not disclosed.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.